MONICA MORALES: Open Payments
NPI 1093092579 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 14 payments from 5 companies in 2025. Trend: 2023 $136 · 2024 $290 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $139 |
| Neurocrine BioSciences, Inc. | 3 | $82 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Alkermes, Inc. | 1 | $19 |
Products named: INGREZZA, AUSTEDO XR, UZEDY, INVEGA SUSTENNA, CAPLYTA, ARISTADA.
Industry payments across KS — which companies pay providers there.
